The Past and Future of Tobacco Regulation

This is a past event

A Health Policy and Bioethics Consortium

Description

After decades of efforts to better regulate the sale of tobacco products, the U.S. has finally seen reductions in overall smoking levels. However, new dangers emerging from growing use of electronic cigarettes have threatened some of these public health advances, leaving the FDA and legislators scrambling. At this event, expert panelists discussed lessons we can learn from past efforts to market tobacco products and past efforts to regulate them that we can apply to the current challenges in this field.

This event was free and open to the public.

Panelists

The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations.

They are organized by the Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women’s Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.